Dr. Rose’s expertise is in the care of patients with genitourinary cancers, including bladder, kidney, prostate, and testicular cancers. She also has extensive training and expertise in clinical trial development and implementation, clinical research methods, public health leadership, and translational science related to immunotherapy combinations and biomarker development.
Master of Public Health: University of North Carolina at Chapel Hill, 2007-2008; Medical School: Duke University, 2005-2009; Internship: Beth Israel Deaconess Medical Center, 2009-2012; Residency: Beth Israel Deaconess Medical Center, 2009-2012; Fellowship: University of North Carolina at Chapel Hill, 2013-2016; Assistant Professor of Medicine: University of North Carolina, 2016-present.
Research and Clinical Interests
Dr. Rose’s clinical interest is in the treatment of patients with genitourinary cancers, including bladder, kidney, prostate, and testicular cancers. She has a focus on the development of novel therapies and combination therapies for patients with urologic malignancies, including the design and implementation of clinical trials. She also studies the molecular alterations that contribute to the development of genitourinary cancers.
I feel extremely fortunate to be a medical oncologist caring for adults with kidney, bladder, prostate, and testis cancers. My career goal is to improve the lives of patients with genitourinary malignancies through excellent patient care including the use of evidence-based medicine and shared decision making. I have a passion for research and work to move cancer research forward through clinical trial development and implementation with the ultimate goal of curing more patients with cancer. I am privileged to help my patients through a difficult time in their lives and energized by the rapid advancements that are happening in cancer therapy.